Sign in
Stories
Biopharmaceutical Expansion and Tech Funding News
Share
COE Premiums Surge; Companies Issue Conv...
Corporate Bond Offerings and Notes
Corporate Investments and Financing Upda...
Allianz Direct Acquires Luko
Cumulus Media Exchange Offer Progress
Escrow Period for Catalyst Metals Shares
Overview
API
Fujifilm commits $4.5bn to biopharmaceutical expansion, UL Solutions prices IPO, VXT secures $1.65m in funding for AI platform.
Ask a question
How will Fujifilm's investment impact the biopharmaceutical industry and its competitors?
In what ways might VXT's AI platform disrupt the legal tech sector and improve legal team efficiency?
What potential market response can be expected from UL Solutions' IPO pricing?
Article Frequency
0.2
0.4
0.6
0.8
1.0
Jan 2024
Feb 2024
Mar 2024
Apr 2024
Coverage